Copyright Reports & Markets. All rights reserved.

Global Active Pharmaceutical Ingredients(API) Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Active Pharmaceutical Ingredients(API) Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Active Pharmaceutical Ingredients(API) Market Size Growth Rate by Product
      • 1.4.2 Synthetic APIs
      • 1.4.3 Biotech APIs
    • 1.5 Market by End User
      • 1.5.1 Global Active Pharmaceutical Ingredients(API) Market Size Growth Rate by End User
      • 1.5.2 Oncology
      • 1.5.3 Diabetes
      • 1.5.4 Cardiovascular Disease
      • 1.5.5 CNS and Neurological Disorders
      • 1.5.6 Endocrinology
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Active Pharmaceutical Ingredients(API) Market Size
      • 2.1.1 Global Active Pharmaceutical Ingredients(API) Revenue 2014-2025
      • 2.1.2 Global Active Pharmaceutical Ingredients(API) Sales 2014-2025
    • 2.2 Active Pharmaceutical Ingredients(API) Growth Rate by Regions
      • 2.2.1 Global Active Pharmaceutical Ingredients(API) Sales by Regions
      • 2.2.2 Global Active Pharmaceutical Ingredients(API) Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Active Pharmaceutical Ingredients(API) Sales by Manufacturers
      • 3.1.1 Active Pharmaceutical Ingredients(API) Sales by Manufacturers
      • 3.1.2 Active Pharmaceutical Ingredients(API) Sales Market Share by Manufacturers
      • 3.1.3 Global Active Pharmaceutical Ingredients(API) Market Concentration Ratio (CR5 and HHI)
    • 3.2 Active Pharmaceutical Ingredients(API) Revenue by Manufacturers
      • 3.2.1 Active Pharmaceutical Ingredients(API) Revenue by Manufacturers (2014-2019)
      • 3.2.2 Active Pharmaceutical Ingredients(API) Revenue Share by Manufacturers (2014-2019)
    • 3.3 Active Pharmaceutical Ingredients(API) Price by Manufacturers
    • 3.4 Active Pharmaceutical Ingredients(API) Manufacturing Base Distribution, Product Types
      • 3.4.1 Active Pharmaceutical Ingredients(API) Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Active Pharmaceutical Ingredients(API) Product Type
      • 3.4.3 Date of International Manufacturers Enter into Active Pharmaceutical Ingredients(API) Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Active Pharmaceutical Ingredients(API) Sales by Product
    • 4.2 Global Active Pharmaceutical Ingredients(API) Revenue by Product
    • 4.3 Active Pharmaceutical Ingredients(API) Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Active Pharmaceutical Ingredients(API) Breakdown Data by End User

    6 North America

    • 6.1 North America Active Pharmaceutical Ingredients(API) by Countries
      • 6.1.1 North America Active Pharmaceutical Ingredients(API) Sales by Countries
      • 6.1.2 North America Active Pharmaceutical Ingredients(API) Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Active Pharmaceutical Ingredients(API) by Product
    • 6.3 North America Active Pharmaceutical Ingredients(API) by End User

    7 Europe

    • 7.1 Europe Active Pharmaceutical Ingredients(API) by Countries
      • 7.1.1 Europe Active Pharmaceutical Ingredients(API) Sales by Countries
      • 7.1.2 Europe Active Pharmaceutical Ingredients(API) Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Active Pharmaceutical Ingredients(API) by Product
    • 7.3 Europe Active Pharmaceutical Ingredients(API) by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Active Pharmaceutical Ingredients(API) by Countries
      • 8.1.1 Asia Pacific Active Pharmaceutical Ingredients(API) Sales by Countries
      • 8.1.2 Asia Pacific Active Pharmaceutical Ingredients(API) Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Active Pharmaceutical Ingredients(API) by Product
    • 8.3 Asia Pacific Active Pharmaceutical Ingredients(API) by End User

    9 Central & South America

    • 9.1 Central & South America Active Pharmaceutical Ingredients(API) by Countries
      • 9.1.1 Central & South America Active Pharmaceutical Ingredients(API) Sales by Countries
      • 9.1.2 Central & South America Active Pharmaceutical Ingredients(API) Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Active Pharmaceutical Ingredients(API) by Product
    • 9.3 Central & South America Active Pharmaceutical Ingredients(API) by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Active Pharmaceutical Ingredients(API) by Countries
      • 10.1.1 Middle East and Africa Active Pharmaceutical Ingredients(API) Sales by Countries
      • 10.1.2 Middle East and Africa Active Pharmaceutical Ingredients(API) Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Active Pharmaceutical Ingredients(API) by Product
    • 10.3 Middle East and Africa Active Pharmaceutical Ingredients(API) by End User

    11 Company Profiles

    • 11.1 Pfizer
      • 11.1.1 Pfizer Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Pfizer Active Pharmaceutical Ingredients(API) Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Pfizer Active Pharmaceutical Ingredients(API) Products Offered
      • 11.1.5 Pfizer Recent Development
    • 11.2 Novartis International
      • 11.2.1 Novartis International Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Novartis International Active Pharmaceutical Ingredients(API) Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Novartis International Active Pharmaceutical Ingredients(API) Products Offered
      • 11.2.5 Novartis International Recent Development
    • 11.3 Sanofi
      • 11.3.1 Sanofi Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Sanofi Active Pharmaceutical Ingredients(API) Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Sanofi Active Pharmaceutical Ingredients(API) Products Offered
      • 11.3.5 Sanofi Recent Development
    • 11.4 Boehringer Ingelheim
      • 11.4.1 Boehringer Ingelheim Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Boehringer Ingelheim Active Pharmaceutical Ingredients(API) Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Boehringer Ingelheim Active Pharmaceutical Ingredients(API) Products Offered
      • 11.4.5 Boehringer Ingelheim Recent Development
    • 11.5 Bristol-Myers Squibb
      • 11.5.1 Bristol-Myers Squibb Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Bristol-Myers Squibb Active Pharmaceutical Ingredients(API) Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Bristol-Myers Squibb Active Pharmaceutical Ingredients(API) Products Offered
      • 11.5.5 Bristol-Myers Squibb Recent Development
    • 11.6 Teva Pharmaceutical
      • 11.6.1 Teva Pharmaceutical Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Teva Pharmaceutical Active Pharmaceutical Ingredients(API) Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Teva Pharmaceutical Active Pharmaceutical Ingredients(API) Products Offered
      • 11.6.5 Teva Pharmaceutical Recent Development
    • 11.7 Eli Lilly and Company
      • 11.7.1 Eli Lilly and Company Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Eli Lilly and Company Active Pharmaceutical Ingredients(API) Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Eli Lilly and Company Active Pharmaceutical Ingredients(API) Products Offered
      • 11.7.5 Eli Lilly and Company Recent Development
    • 11.8 GlaxoSmithKline
      • 11.8.1 GlaxoSmithKline Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 GlaxoSmithKline Active Pharmaceutical Ingredients(API) Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 GlaxoSmithKline Active Pharmaceutical Ingredients(API) Products Offered
      • 11.8.5 GlaxoSmithKline Recent Development
    • 11.9 Merck & Co
      • 11.9.1 Merck & Co Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Merck & Co Active Pharmaceutical Ingredients(API) Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Merck & Co Active Pharmaceutical Ingredients(API) Products Offered
      • 11.9.5 Merck & Co Recent Development
    • 11.10 AbbVie
      • 11.10.1 AbbVie Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 AbbVie Active Pharmaceutical Ingredients(API) Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 AbbVie Active Pharmaceutical Ingredients(API) Products Offered
      • 11.10.5 AbbVie Recent Development
    • 11.11 Johnson & Johnson
    • 11.12 Bayer
    • 11.13 Sun Pharmaceutical Industries
    • 11.14 DSM
    • 11.15 Hisun Pharmacy
    • 11.16 Huahai Pharmaceutical
    • 11.17 North China Pharmaceutical Group
    • 11.18 Shandong Lukang Pharmaceutical
    • 11.19 Haerbin Pharmaceutical Group
    • 11.20 Shandong Xinhua Pharmaceutical
    • 11.21 Jiangsu Hengrui Medicine
    • 11.22 Lonza Group
    • 11.23 Aurobindo Pharma
    • 11.24 Lupin
    • 11.25 Biocon

    12 Future Forecast

    • 12.1 Active Pharmaceutical Ingredients(API) Market Forecast by Regions
      • 12.1.1 Global Active Pharmaceutical Ingredients(API) Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Active Pharmaceutical Ingredients(API) Revenue Forecast by Regions 2019-2025
    • 12.2 Active Pharmaceutical Ingredients(API) Market Forecast by Product
      • 12.2.1 Global Active Pharmaceutical Ingredients(API) Sales Forecast by Product 2019-2025
      • 12.2.2 Global Active Pharmaceutical Ingredients(API) Revenue Forecast by Product 2019-2025
    • 12.3 Active Pharmaceutical Ingredients(API) Market Forecast by End User
    • 12.4 North America Active Pharmaceutical Ingredients(API) Forecast
    • 12.5 Europe Active Pharmaceutical Ingredients(API) Forecast
    • 12.6 Asia Pacific Active Pharmaceutical Ingredients(API) Forecast
    • 12.7 Central & South America Active Pharmaceutical Ingredients(API) Forecast
    • 12.8 Middle East and Africa Active Pharmaceutical Ingredients(API) Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Active Pharmaceutical Ingredients(API) Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Active Pharmaceutical Ingredients(API) market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Active Pharmaceutical Ingredients(API) market based on company, product type, end user and key regions.

      This report studies the global market size of Active Pharmaceutical Ingredients(API) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Active Pharmaceutical Ingredients(API) in these regions.
      This research report categorizes the global Active Pharmaceutical Ingredients(API) market by top players/brands, region, type and end user. This report also studies the global Active Pharmaceutical Ingredients(API) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Pfizer
      Novartis International
      Sanofi
      Boehringer Ingelheim
      Bristol-Myers Squibb
      Teva Pharmaceutical
      Eli Lilly and Company
      GlaxoSmithKline
      Merck & Co
      AbbVie
      Johnson & Johnson
      Bayer
      Sun Pharmaceutical Industries
      DSM
      Hisun Pharmacy
      Huahai Pharmaceutical
      North China Pharmaceutical Group
      Shandong Lukang Pharmaceutical
      Haerbin Pharmaceutical Group
      Shandong Xinhua Pharmaceutical
      Jiangsu Hengrui Medicine
      Lonza Group
      Aurobindo Pharma
      Lupin
      Biocon

      Market size by Product
      Synthetic APIs
      Biotech APIs
      Market size by End User
      Oncology
      Diabetes
      Cardiovascular Disease
      CNS and Neurological Disorders
      Endocrinology

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Active Pharmaceutical Ingredients(API) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Active Pharmaceutical Ingredients(API) market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Active Pharmaceutical Ingredients(API) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Active Pharmaceutical Ingredients(API) submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Active Pharmaceutical Ingredients(API) are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Active Pharmaceutical Ingredients(API) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now